Board Meeting5 Nov 2026, 03:53 pm
Titan Biotech Ltd Board Approves Unaudited Financial Results for Q2 FY27
AI Summary
Titan Biotech Limited announced the outcome of its Board Meeting held on November 05, 2026. The Board of Directors approved the Unaudited Standalone and Consolidated financial results for the quarter and half-year ended September 30, 2026. These results were reviewed by the Audit Committee prior to board approval. The company also provided the Limited Review Report issued by its statutory auditors. The meeting commenced at 3:00 PM and concluded at 3:32 PM. The financial information will be available on the company's website and the BSE website.
Key Highlights
- Board approved unaudited standalone and consolidated financial results.
- Results are for the quarter and half-year ended September 30, 2026.
- Audit Committee reviewed the financial results before board approval.
- Limited Review Report from statutory auditors is enclosed.
- Information to be available on company and BSE websites.
Price Impact
More from TITANBIO